Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 October 2020 | Story Leonie Bolleurs | Photo Jolandi Griesel
Dr Michael von Maltitz embraces the possibilities that the internet provides for education. He wants his students to be comfortable evaluating and using information from the internet to solve their problems.

“My research in teaching and learning is driven mostly by curiosity – when I feel something is not working in a class, I look for alternatives and I am quick to adopt something new.”

This is how Dr Michael von Maltitz approaches his research. This perspective on things is also what brought him an award from the Centre for Teaching and Learning (CTL) during the Annual UFS Excellence in Learning and Teaching Conference 2020 that was held on 21 and 22 September 2020. 

Dr Von Maltitz, who is Programme Director and Senior Lecturer in the Department of Mathematical Statistics and Actuarial Science, received an Excellence in Learning and Teaching award in the category Technology Enhanced Learning. 

He teaches Causal Inference and Generalised Linear Models for third-year Mathematical Statistics students, and Sampling Distribution Theory for second-year Mathematical Statistics students. 

Follow the lead of practice

Grabbing the attention of the judges, he believes, was his passion for new teaching and learning methods. He is also of the opinion that it is important to embrace the information – the incredible amount of free, valuable content online – that is freely available to staff and students all the time.

“I am passionate about the fact that we need to stop asking our students to write tests when this is not done in that student’s industry. At university, we need to assess knowledge in the same way it is assessed in practice. This ultimately means that information capturing (which is what we expect from students in a textbook-to-test format) should be left to machines and the internet. Critical thinking, knowledge valuation, and self-assessment (i.e. facets of learning how to learn) should be developed while at university.”

“The internet is everywhere now, and we’re fooling ourselves if we think we can teach our students how to navigate their futures without incorporating the internet into our teachings,” he adds.

Dr Von Maltitz embraces the possibilities that the internet provides. “Hopefully, when my students are finished with my modules, they will be more comfortable evaluating and using information from the internet to solve their problems, like I do on a day-to-day basis,” he says. 

Seeking new methods

On receiving this award, Dr Von Maltitz voiced his gratitude for the opportunity to present his ideas and practices; “it suggests that others might find my work useful”.

He says that it helps him feel justified in trying new methods in teaching and learning every year.

Dr Von Maltitz has big plans for the next five years. He wants to make it to Associate Professor, partially on the strength of his teaching and learning portfolio.

“My goal is to ensure that my gradual exploration of my research field in Mathematical Statistics always raises the impact of my modules for my students and improves the quality and quantity of my postgraduate supervision. I also hope that my teaching and learning research will continue to improve my ability to transform my students into life-long learners.”


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept